Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Platinum-Based Chemotherapy | Risk Factors for Hearing Loss

MyLikes

MyPaths
Purpose:
To identify risk factors for hearing loss in a patient treated with cisplatin or other platinum-based chemotherapy.
Specialty
  • Hematology Oncology
    Otolaryngology
    Pharmacology
  • Clinical
Objective
  • Risk factors
  • Response to therapy
  • Complication detection
ICD-10
  • H91.0

In order to access the algorithms, please subscribe to a plan that fits your needs.

MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Platinum-Based Chemotherapy | Risk Factors for Hearing Loss
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.